These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29177382)

  • 1. [High frequency of dyslipidemia in VIH-infected patients in aa peruvian public hospital].
    Rondan PL; Flores-Flores O; Doria NA; Valencia-Mesias G; Chávez-Pérez V; Soria J
    Rev Peru Med Exp Salud Publica; 2017; 34(2):239-244. PubMed ID: 29177382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil.
    Ceccato MG; Bonolo PF; Souza Neto AI; Araújo FS; Freitas MI
    Braz J Med Biol Res; 2011 Nov; 44(11):1177-83. PubMed ID: 22052375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.
    Rahman AP; Eaton SA; Nguyen ST; Bain AM; Payne KD; Bedimo R; Busti AJ
    Pharmacotherapy; 2008 Jul; 28(7):913-9. PubMed ID: 18576906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.
    Manuthu EM; Joshi MD; Lule GN; Karari E
    East Afr Med J; 2008 Jan; 85(1):10-7. PubMed ID: 18543521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia in AIDS patients on highly active antiretroviral therapy.
    Nery MW; Martelli CM; Turchi MD
    Braz J Infect Dis; 2011; 15(2):151-5. PubMed ID: 21503402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia, Diet and Physical Exercise in Children on Treatment With Antiretroviral Medication in El Salvador: A Cross-sectional Study.
    Sonego M; Sagrado MJ; Escobar G; Lazzerini M; Rivas E; Martín-Cañavate R; Pérez de López E; Ayala S; Castaneda L; Aparicio P; Custodio E
    Pediatr Infect Dis J; 2016 Oct; 35(10):1111-6. PubMed ID: 27254031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.
    Mandal A; Mukherjee A; Lakshmy R; Kabra SK; Lodha R
    Indian J Pediatr; 2016 Mar; 83(3):226-31. PubMed ID: 26334860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART).
    Lapphra K; Vanprapar N; Phongsamart W; Chearskul P; Chokephaibulkit K
    J Med Assoc Thai; 2005 Jul; 88(7):956-66. PubMed ID: 16241026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
    Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
    Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trial.
    Lazzaretti RK; Kuhmmer R; Sprinz E; Polanczyk CA; Ribeiro JP
    J Am Coll Cardiol; 2012 Mar; 59(11):979-88. PubMed ID: 22402068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
    Glass TR; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC;
    HIV Clin Trials; 2007; 8(2):77-85. PubMed ID: 17507323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
    Hiransuthikul N; Hiransuthikul P; Kanasook Y
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rosuvastatin for the treatment of dyslipidemia in HIV-infected patients receiving highly active antiretroviral therapy. Preliminary experience].
    Bottaro EG; Caravello O; Scapellato PG; Stambulian M; Vidal GI; Loggia V; Scapellato JL; Thompson F; Cassetti I
    Enferm Infecc Microbiol Clin; 2008; 26(6):325-9. PubMed ID: 18588813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
    Achila OO; Abrhaley F; Kesete Y; Tesfaldet F; Alazar F; Fisshaye L; Gebremeskel L; Mehari R; Andemichael D
    PLoS One; 2022; 17(7):e0270838. PubMed ID: 35776747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe dyslipidemia and immune activation in HIV patients with dysglycemia.
    Jin C; Ji S; Xie T; Höxtermann S; Fuchs W; Lu X; Wu H; Cheng L; Skaletz-Rorowski A; Brockmeyer NH; Wu N
    HIV Clin Trials; 2016 Sep; 17(5):189-96. PubMed ID: 27409415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
    Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
    Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy.
    Chuapai Y; Kiertiburanakul S; Malathum K; Sungkanuparph S
    J Med Assoc Thai; 2007 Mar; 90(3):452-8. PubMed ID: 17427520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: A cross-sectional study.
    Yang CJ; Wang HY; Chou TC; Chang CJ
    J Microbiol Immunol Infect; 2019 Oct; 52(5):720-727. PubMed ID: 31358463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.